Price
$1.31
Decreased by -0.76%
Dollar Volume
96.70 K
ADR%
8.77
Earnings Report Date (estimate)
Mar 20, 23 (N/A)
Market Cap.
9.74 M
Shares Float
6.74 M
Shares Outstanding
7.44 M
Beta
1.64
Price / Earnings
-0.23
BPR
93.76
20D Range
1.01 1.48
50D Range
1.00 1.48
200D Range
0.94 3.30
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Aug 11, 22 -0.94
Decreased by -2.25 K%
-1.09
Increased by +13.76%
May 10, 22 -2.33
Decreased by -3.23 K%
-1.17
Decreased by -99.15%
Mar 22, 22 -1.26
Decreased by -1.70 K%
-1.26
Nov 11, 21 -0.06
Increased by +25.00%
-0.07
Increased by +14.29%
Aug 10, 21 -0.04
Increased by +77.78%
-0.04
May 6, 21 -0.07
Increased by +85.11%
-0.04
Decreased by -75.00%
Mar 11, 21 -0.07
Increased by +87.93%
-0.06
Decreased by -16.67%
Nov 10, 20 -0.08
Increased by +88.57%
-0.10
Increased by +20.00%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 2.25 M
Decreased by -4.82%
0.00
Increased by +100.00%
Increased by 0.00%
Increased by +100.00%
Jun 30, 22 2.13 M
Decreased by -23.91%
-4.21 M
Decreased by -71.86%
Decreased by -197.65%
Decreased by -125.87%
Mar 31, 22 1.89 M
Decreased by -26.22%
-5.14 M
Decreased by -1.74%
Decreased by -272.25%
Decreased by -37.90%
Dec 31, 21 -2.77 M
Decreased by -201.21%
0.00
Increased by +100.00%
Increased by 0.00%
Increased by +100.00%
Sep 30, 21 2.37 M
Increased by +2.78%
-4.91 M
Decreased by -8.55%
Decreased by -207.61%
Decreased by -5.62%
Jun 30, 21 2.80 M
Increased by +91.13%
-2.45 M
Increased by +38.70%
Decreased by -87.51%
Increased by +67.93%
Mar 31, 21 2.56 M
Increased by +13.18%
-5.05 M
Increased by +13.66%
Decreased by -197.42%
Increased by +23.71%
Dec 31, 20 2.73 M
Increased by +6.64%
-4.63 M
Increased by +9.59%
Decreased by -169.47%
Increased by +15.21%
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.